“Effect of Spesolimab on Achieving Sustained Disease Remission in Patients with Generalized Pustular Psoriasis: Results from the Effisayil 2 Study” (2024) SKIN The Journal of Cutaneous Medicine, 8(2), p. s357. doi:10.25251/skin.8.supp.357.